Crossmark

Development of predictive models for pathological response status in breast cancer after neoadjuvant therapy based on peripheral blood inflammatory indexes

Crossref DOI link: https://doi.org/10.1186/s12905-024-03400-9

Published Online: 2024-10-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Liu, Shuqiang

Jiang, Cong

Wu, Danping

Zhang, Shiyuan

Qiao, Kun

Yang, Xiaotian

Yu, Boqian

Huang, Yuanxi
License Information

Text and Data Mining valid from 2024-10-12

Version of Record valid from 2024-10-12
More Information

Article History

Received: 15 August 2024

Accepted: 3 October 2024

First Online: 12 October 2024

Declarations

:

: This study was approved by the Clinical Research Ethics Committee of the Harbin Medical University Cancer Hospital. This research complies with the 1964 World Medical Association Declaration of Helsinki and subsequently amended versions. All patients were provided with written informed consent prior to participation.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below